Go Pro

BioCryst Pharmaceuticals (BCRX) News Today

BioCryst Pharmaceuticals logo
$9.83 +0.15 (+1.55%)
Closing price 04:00 PM Eastern
Extended Trading
$9.85 +0.02 (+0.15%)
As of 05:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BioCryst Pharmaceuticals Latest News

Equities Analysts Offer Predictions for BCRX Q3 Earnings
What is HC Wainwright's Forecast for BCRX Q3 Earnings?
HC Wainwright Issues Optimistic Outlook for BCRX Earnings
Research Analysts Issue Forecasts for BCRX Q4 Earnings
BioCryst Pharmaceuticals, Inc. (BCRX)
BioCryst Pharmaceuticals Q2 Earnings Call Highlights
BioCryst: Q2 Earnings Snapshot
BioCryst Reports Second Quarter 2026 Financial Results

BioCryst Pharmaceuticals Media Mentions By Week

BioCryst Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BCRX
News Sentiment

1.24

0.68

Average
Healthcare
News Sentiment

BioCryst Pharmaceuticals News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BCRX Articles
This Week

7

6

BCRX Articles
Average Week

BioCryst Pharmaceuticals Trends on MarketBeat

This week vs. last week
New Followers
1
Searches
2
-33%
Page Views
2,190
-12%
Get BioCryst Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCRX and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for BioCryst Pharmaceuticals dated 8/25/2026.
From Our Partners